NEUPULSE
Neupulse is the brand of Neurotherapeutics Ltd The direction of our current research was very much shaped by the feedback we received from individuals with tic disorders and their families. When we asked them for their thoughts on our research priorities we were frequently told that what was really needed was a safe and effective non-drug treatment for tic disorder that could be used outside of the clinic and gave individuals control over their tics. This led directly to us focusing on the us... e of peripheral nerve stimulation as a means of bringing about changes in the brain networks associated with the production of tics. We demonstrated that delivering rhythmic patterns of mild electrical stimulation to the median nerve at the wrist could be used to increase the power and the synchronicity of the brain oscillations (rhythms) associated with the suppression of movements, and that this type of stimulation was sufficient to dramatically reduce the frequency of tics and remove the urge-to-tic in individuals with tic disorders. Importantly, we also showed that this type of stimulation did not materially affect the execution of volitional (intentional) movements or impair cognitive functions such as attention.
NEUPULSE
Social Links:
Industry:
Health Care
Founded:
2021-02-12
Address:
Nottingham, Nottingham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.neupulse.co.uk
Total Employee:
1+
Status:
Active
Current Employees Featured
Official Site Inspections
http://www.neupulse.co.uk Semrush global rank: 2.09 M Semrush visits lastest month: 9.92 K
- Host name: 768728.cloudwaysapps.com
- IP address: 167.71.136.77
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Neupulse"
Neupulse - Improving the lives of people with Tourettes
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes …See details»
About NeuPulse - We focus on non-invasive brain stimulation to …
At Neupulse, we are not just developing a medical device; we are pioneering a change in the Tourette syndrome therapeutic landscape. Our commercial strategy is focused on bringing this …See details»
FAQs - neupulse.co.uk
We are aiming to launch the device called ‘Neupulse’ in 2026 following regulatory approval ensuring its compliance to all relevant safety, quality and regulatory requirements. How can …See details»
Latest news on TS - Neupulse Clinical Trial - Tourettes Action
Mar 12, 2023 · We are excited to share the results of the UK-wide double-blind sham-controlled clinical trial of the Neupulse device for suppressing tics in Tourette syndrome. The trial was …See details»
Developer behind wearable device for Tourettes …
Mar 18, 2024 · Neupulse, a UK-based company that is developing a wristband to help manage the symptoms of Tourette’s syndrome, has raised $3.2m in seed financing. The trade name of Neurotherapeutics Limited, Neupulse spun out …See details»
'Life changing' Tourette's gadget trialled - BBC News
Jun 20, 2022 · A device to help people with Tourette's syndrome has been developed by experts at the University of Nottingham. The smartwatch-like gadget aims to reduce the involuntary sounds and movements, known...See details»
Nottingham spin-out raises almost £1m to commercialise …
Jan 20, 2023 · A new wrist device to help control Tourette’s Syndrome is a step closer to being commercialised after University of Nottingham spin-out company Neupulse raised almost £1m …See details»
Neupulse - LinkedIn
At Neupulse we are on a mission to transform the lives of those living with Tourette Syndrome by bringing our innovative wearable wrist-worn device to market. We are committed to ensuring...See details»
Neupulse Secures Funding to Advance World’s First Wearable …
Mar 18, 2024 · Neupulse has secured a $3.2 million seed stage investment led by Scottish impact investor Eos Advisory, alongside a consortium including US-based investors, as Neupulse …See details»
Lewis Capaldi pops into university to try Tourettes wrist …
Jan 30, 2023 · This Neupulse device, based on research conducted at the University of Nottingham, is now being developed by a University spin-out company, Neurotherapeutics Ltd, to help the millions of people worldwide who …See details»
Neupulse Solutions - App and Wrist Device
In a UK-wide double-blind sham-controlled clinical trial, we have established the positive impact of home administration of median nerve stimulation in reducing both the frequency and severity of tics in individuals with Tourette syndrome.See details»
Neupulse: Tourettes Therapy Device - Kinneir Dufort
There is no cure for Tourettes but a team at the University of Nottingham have developed a therapy based on applying mild electrical stimulation in rhythmic patterns to the median nerve …See details»
Promising wearable device may help people manage Tourette …
Nov 15, 2023 · Researchers from the University of Nottingham, in collaboration with a company called Neurotherapuetics Ltd, developed the Neupulse device, which works by sending …See details»
Latest news on TS - New website launch - Tourettes Action
Apr 6, 2022 · Neurotherapeutics Ltd, the company that is using Professor Stephen Jacksons research work to develop a wearable device that will help reduce the urge to tic, have …See details»
Meet our team - Neupulse
Stephen Jackson is a Founder and Chief Scientific Officer of Neurotherapeutics Ltd, Professor of Cognitive Neuroscience at the University of Nottingham and has over 30 years research …See details»
Nottingham company's Tourette’s wristband wins backing from …
Nov 21, 2024 · A device developed by a Nottingham company to ease the symptoms of Tourette’s syndrome has been recommended for use in the NHS by the National Institute for Health and …See details»
Neupulse secures funding to advance world’s first wearable device …
Mar 18, 2024 · Neupulse has secured a £2.5 million seed stage investment led by Scottish impact investor Eos Advisory, alongside a consortium including US-based investors, as Neupulse …See details»
Neupulse Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Neupulse. Use the PitchBook Platform to explore the full profile.See details»
PRA statement in relation to the MiFID Org Reg | Bank of England
Nov 15, 2024 · Such a consultation represents an important step in the adaptation of the UK’s prudential regime for CRR firms inherited from the European Union (EU) into a framework …See details»
Webinar - Update on the wearable wrist device - Tourettes Action
Apr 2, 2024 · Find out more about the progress and development of the wearable wrist device, from Neupulse, that delivers electrical pulses to reduce the amount and severity of tics …See details»